Description:
Biogen Inc. is a prominent biotechnology company headquartered in Cambridge, Massachusetts, specializing in the discovery and development of groundbreaking therapies for neurological disorders. With an extensive pipeline targeting significant conditions such as multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy, Biogen is positioned as a critical player in addressing substantial unmet medical needs in the healthcare landscape. The company's focus on advancing therapeutic innovation is complemented by strategic collaborations and a strong commitment to scientific research, underscoring its leadership within the biotechnology sector and dedication to enhancing patient outcomes globally.
Industry:
DRUG MANUFACTURERS - GENERAL
Address:
225 BINNEY STREET, CAMBRIDGE, MA, UNITED STATES, 02142
Fiscal year end:
December
Market capitalization:
$27.5 Billion
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-43%
How much will you get:
$574
Prices dates:
31-12-2015: $306.35 and 31-12-2025: $175.99